Condition: Triangular Fibrocartilage Complex Injury · Sponsor: Tampere University Hospital
The trial is a multicentre, randomized, superiority, controlled, participant and outcome assessor (debridement versus placebo surgery randomization cohort) and trialist blinded (both arms) superiority, umbrella trial with two randomized cohorts (1. debridement or placebo surgery, 2. repair or physiotherapy) which both include two 1:1 parallel arms. The primary objective is to investigate the superiority of 1) debridement over placebo surgery and 2) repair over physiotherapy in two randomized cohorts using Patient-Rated Wrist Evaluation (PRWE) at one year post randomisation as the primary outcome.
This description comes directly from the study's public registry record.
Ville M Mattila, M.D., Ph.D., Professor · +3583311611 · ville.mattila@tuni.fi
Jarkko Jokihaara, M.D., Ph.D., Professor · +3583311611 · jarkko.jokihaara@tuni.fi
Always discuss trial participation with your own doctor first.
| Herlev/Gentofte University Hospital of Copenhagen | Copenhagen, Denmark | Recruiting |
| Hospital Sønderjylland | Sønderborg, Denmark | Recruiting |
| Hospital Nova of Central Finland | Jyväskylä, Central Finland, Finland | Recruiting |
| Oulu University Hospital | Oulu, North Ostrobothnia, Finland | Recruiting |
| Kuopio University Hospital | Kuopio, Northern Savonia, Finland | Recruiting |
| Tampere University Hospital | Tampere, Pirkanmaa, Finland | Recruiting |
| Turku University Hospital | Turku, Southwest Finland, Finland | Recruiting |
| Helsinki University Hospital | Helsinki, Uusimaa, Finland | Recruiting |
| Karolinska University Hospital | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04576169